Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
Hao Zhang(Northwestern Polytechnical University), Quan Cheng(Central South University), Wantao Wu(Central South University), Nan Zhang(Huazhong University of Science and Technology), Zeyu Wang(Anhui University), Shuyu Li(Xuzhou Medical College), Hui Cao(Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Ziyu Dai(Central South University)
Cited by 47
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400